You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 19, 2024

CLINICAL TRIALS PROFILE FOR SULFAMYLON

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for SULFAMYLON

Subscribe to access the full database, or Try a Trial
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00634166 ↗	Prospective Evaluation of the Effects of Topical Therapy With Sulfamylon® For 5% Topical Solution on Autograft Healing in Subjects With Thermal Injuries Requiring Meshed Autografts: A Comparison to a Historical Control Group	Terminated	Mylan Pharmaceuticals	Phase 4	2007-09-01	The primary objective is to compare the effectiveness of treatment with Sulfamylon® solution as the initial topical moist dressing over meshed autografts following the initial graft procedure on preventing graft loss in a prospective cohort of subjects versus a historical control group in a non-inferiority trial.
NCT00634166 ↗	Prospective Evaluation of the Effects of Topical Therapy With Sulfamylon® For 5% Topical Solution on Autograft Healing in Subjects With Thermal Injuries Requiring Meshed Autografts: A Comparison to a Historical Control Group	Terminated	Mylan Bertek Pharmaceuticals	Phase 4	2007-09-01	The primary objective is to compare the effectiveness of treatment with Sulfamylon® solution as the initial topical moist dressing over meshed autografts following the initial graft procedure on preventing graft loss in a prospective cohort of subjects versus a historical control group in a non-inferiority trial.
NCT00675922 ↗	Study of the Treatment of Burn Wounds With Antimicrobial Topical Soaks	Terminated	The University of Texas Medical Branch, Galveston	Phase 2/Phase 3	1995-07-01	Determine effectiveness of various antimicrobial solutions on burn wounds (infections, wound healing, length of hospital stay).
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for SULFAMYLON

Condition Name

Chart
Table

Condition Name for SULFAMYLON
Intervention	Trials
Burn	1
Burns	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for SULFAMYLON
Intervention	Trials
Burns	2
Wounds and Injuries	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for SULFAMYLON

Trials by Country

Map
Table

Trials by Country for SULFAMYLON
Location	Trials
United States	9
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for SULFAMYLON
Location	Trials
Texas	1
North Carolina	1
Missouri	1
Maryland	1
Kansas	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for SULFAMYLON

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for SULFAMYLON
Clinical Trial Phase	Trials
Phase 4	1
Phase 2/Phase 3	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for SULFAMYLON
Clinical Trial Phase	Trials
Terminated	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for SULFAMYLON

Sponsor Name

Chart
Table

Sponsor Name for SULFAMYLON
Sponsor	Trials
Mylan Pharmaceuticals	1
Mylan Bertek Pharmaceuticals	1
The University of Texas Medical Branch, Galveston	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for SULFAMYLON
Sponsor	Trials
Industry	2
Other	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.